Anixa Biosciences, Inc. (ANIX)
ANIX Stock Price Chart
Explore Anixa Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze ANIX price movements and trends.
ANIX Company Profile
Discover essential business fundamentals and corporate details for Anixa Biosciences, Inc. (ANIX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 Oct 1983
Employees
5.00
Website
https://www.anixa.comCEO
Amit Kumar
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
ANIX Financial Timeline
Browse a chronological timeline of Anixa Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 May 2026
Upcoming earnings on 9 Mar 2026
Earnings released on 12 Sept 2025
Earnings released on 28 May 2025
EPS came in at -$0.09 surpassing the estimated -$0.10 by +10.00%.
Earnings released on 11 Mar 2025
EPS came in at -$0.10 matching the estimated -$0.10.
Earnings released on 10 Jan 2025
EPS came in at -$0.09 surpassing the estimated -$0.11 by +18.18%.
Earnings released on 6 Sept 2024
EPS came in at -$0.10 surpassing the estimated -$0.11 by +9.09%.
Earnings released on 4 Jun 2024
EPS came in at -$0.10 surpassing the estimated -$0.11 by +9.09%.
Earnings released on 12 Mar 2024
EPS came in at -$0.10 falling short of the estimated -$0.09 by -11.11%.
Earnings released on 16 Jan 2024
EPS came in at -$0.09 matching the estimated -$0.09, while revenue for the quarter reached $156.00K .
Earnings released on 6 Sept 2023
EPS came in at -$0.08 surpassing the estimated -$0.09 by +11.11%.
Earnings released on 14 Jun 2023
EPS came in at -$0.07 surpassing the estimated -$0.11 by +36.36%, while revenue for the quarter reached $210.00K .
Earnings released on 16 Mar 2023
EPS came in at -$0.08 surpassing the estimated -$0.16 by +50.00%.
Earnings released on 4 Jan 2023
EPS came in at -$0.12 surpassing the estimated -$0.13 by +7.69%, while revenue for the quarter reached $2.47B .
Earnings released on 9 Sept 2022
EPS came in at -$0.09 surpassing the estimated -$0.13 by +30.77%.
Earnings released on 10 Jun 2022
EPS came in at -$0.12 surpassing the estimated -$0.13 by +7.69%.
Earnings released on 11 Mar 2022
EPS came in at -$0.13 matching the estimated -$0.13.
Earnings released on 4 Jan 2022
EPS came in at -$0.13 , while revenue for the quarter reached $3.61M .
Earnings released on 1 Sept 2021
EPS came in at -$0.14 falling short of the estimated -$0.08 by -75.00%.
Earnings released on 10 Jun 2021
EPS came in at -$0.08 surpassing the estimated -$0.10 by +20.00%.
Earnings released on 11 Mar 2021
EPS came in at -$0.09 surpassing the estimated -$0.11 by +18.18%, while revenue for the quarter reached $512.50K , missing expectations by -15.38%.
Earnings released on 7 Jan 2021
EPS came in at -$0.81 , while revenue for the quarter reached -$124.36K .
ANIX Stock Performance
Access detailed ANIX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.